Author

Na Kong

First Affiliated Hospital Zhejiang UniversityPrimary ORCID profile (0000-0002-6613-1957 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Na KongiD1 paper · Zhejiang University

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Anhua Lei· 1 shared Hailing Zhang· 1 shared Hengxing Lu· 1 shared Jin ZhangiD· 1 shared Qixin Wu· 1 shared Shaolong ZhangiD· 1 shared Xizhong Ding· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Anhua Lei

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

In vivo engineered quadrivalent CAR-macrophages break tumor barrier,remodel TME and overcome tumor heterogeneity through antigen spreading

Shaolong Zhang, Hengxing Lu, Hailing Zhang, Xizhong Ding, Qixin Wu, Anhua Lei, Na Kong, Jin Zhang

This study develops in vivo engineered quadrivalent CAR-macrophages that break tumor barriers, remodel the TME, and overcome tumor heterogeneity through antigen spreading, achieving complete tumor regression.

bioRxiv · Nov 6, 2024 · PreprintBioengineering